Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks
MiniMed insulin pumps have a history of problems that have led to numerous recalls over the last decade, following reports of over or under delivery of insulin.
MiniMed insulin pumps have a history of problems that have led to numerous recalls over the last decade, following reports of over or under delivery of insulin.
Nearly 30,000 Omnipod 5 insulin delivery systems are being recalled over the risk that the devices may delivery incorrect insulin doses.
Wrongful death lawsuit alleges that family was informed of a Medtronic MiniMed recall just days after a fatal insulin pump overdose occurred, when one of the pumps malfunctioned.
Two federal judges have dismissed individual Medtronic MiniMed insulin pump lawsuits, saying FDA approval of the devices means they cannot face liability for manufacturing or design defect claims.
Medtronic does not indicate whether the newly approved MiniMed insulin pump resolves problems which have led to numerous recalls in recent years.
New warning is the latest problem linked to Medtronic MiniMed 600 insulin pumps, which have been subject to a series of recalls in recent years, and blamed for thousands of serious injuries.
Failure to come clean about MiniMed insulin pump problems led to Medtronic investor losses, according to allegations raised in securities fraud lawsuit.
The MiniMed 630G pump was recalled in November 2019, just months before plaintiff's husband went into an insulin-induced coma and died.
Concerns over problems with Medtronic MiniMed pumps malfunctioning led to a recall in February 2020.
The insulin pumps have been subject to several recalls in recent years.